Drugs / NU172
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00808964 | Jan → Jun 2013 | heart disorder | ARCA Biopharma, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NU172 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00808964 ↗ |
| Route | Intravenous | “NU172 administered IV bolus followed by continuous infusion during CABG surgery” NCT00808964 ↗ |